Local Expertise Global Outcome

Delivering high-quality clinical trial services in Europe
since 2005

Request a Callback

15 years’ experience managing clinical trials in Europe

300+ clinical studies in portfolio

Team of 200+ clinical operations professionals

FDA/EMA acceptable data

Access to a network of 1600+ leading scientific sites

50,000+ patients recruited

Tailored approach to every project ●

1.5 x faster enrollment rate for any area ●

An email or a phone call away ●

Full Range of Clinical Trial Services

Clinical Study Design Preparation

Consulting and Regulatory Support

Medical Writing

Drug Safety and Pharmacovigilance

Project Management and Monitoring

Data Management and Biostatistics

Marketing Authorization

GMP Inspection Support

Clinical Supply Services and Logistics

We never settle for a compromise when choosing between quality, timeline and budget. We always deliver the best on all three.

Irina Petrova, MD
Director of Clinical Operations

Our goal is to become your trusted partner. If you work with us, all issues are resolved instantly, only a phone call or an email away, within 24 hours.

Andrei Stefashin
Senior Project Manager

300+ Studies in 29 Therapeutic Areas
Since 2005

Oncology

Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer and other oncology indications

Respiratory Diseases

Bronchial Asthma, Asthma, Tuberculosis, Pneumonia and other respiratory indications

Gastroenterology

Ulcerative Colitis, Bowel Disease, Crohn's Disease and other gastroenterology indications

Neurology

Alzheimer’s, Sclerosis, Mild cognitive impairment and other neurology indications

Rheumatology

Rheumatoid arthritis, Osteoarthritis and other rheumatology indications

Infectious Diseases

Influenza, HIV, Hepatitis B and other infectious diseases indications

All Therapeutic Areas

OCT Clinical to the Rescue

Rescue Studies as a Special Expertise

When clinical trials hit roadblocks, we are ready to step in. Each time we takeover an active trial, our experts create a study rescue plan focused on resolving current bottlenecks and study challenges and an expedited study schedule to get it back on track.

Request a Proposal

Our Clients

Other Clients >>

Media Room

COVID-19 and Clinical Trials: a CRO's Perspective

In the light of the global pandemic with have prepared an interview with OCT's Clinical Operations Director, Irina Petrova…

OCT to Remain Fully Operational, Available to Clients re: COVID-19

A message from the CEO: We will continue to stand by you and we will commit ourselves fully to the projects you have entrusted…

[Industry Voice #1] 2020 by Maxime Stevens: sponsors, patients, CROs, eClinical

Maxime Stevens, Chief Strategy and Development Officer at OCT Clinical, talking about trends that will likely transform the…

Phase III Ophthalmology Study (Glaucoma, Ocular Hypertension)

The multicenter, randomized, double-blind, investigator-masked, placebo-controlled phase III study will run in two parallel…

Bioequivalence Study with marketing authorization for all EAEU member states

Leading mid-size European CRO approved to begin work on bioequivalence study.

OCT Clinical Begins Enrollment for Phase III Ophthalmology Study

This is a randomized, multi-center, double-blind Phase II study, the primary goal of which is to evaluate the safety and…

All Media Resources >>

OCT Clinical on the Road

BIO 2020

June 8-11, 2020
USA, San Diego

Let’s meet up to discuss your clinical trial options

Get in Touch with OCT Clinical